Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation

Oncogene

Volumn 22, Issue 32, 2003, Pages 5006-5010

  Harvey, Amanda J ^a   Crompton, Mark R ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Breast cancer; Proliferation; Protein tyrosine kinase; RNA interference; Small interfering RNA

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN BRK; PROTEIN TYROSINE KINASE; RNA; UNCLASSIFIED DRUG; PTK6 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME MECHANISM; GENE MUTATION; HUMAN; HUMAN CELL; MITOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA ANALYSIS; RNA INTERFERENCE; VALIDATION PROCESS; BREAST TUMOR; CARCINOMA; CELL CULTURE; CELL DIVISION; FEMALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; FEMALE; HUMANS; NEOPLASM PROTEINS; PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; TUMOR CELLS, CULTURED;

EID: 0042786007     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206577     Document Type: Article

References (21)

1. Barker KT, Jackson LE and Crompton MR. (1997). Oncogene, 15, 799-805.
2. Caplen NJ, Parrish S, Imani F, Fire A and Morgan RA. (2001). Proc. Natl. Acad. Sci. USA, 98, 9742-9747.
3. Derry JJ, Richard S, Valderrama Carvajal H, Ye X, Vasioukhin V, Cochrane AW, Chen T and Tyner AL. (2000). Mol. Cell. Biol., 20, 6114-6126.
4. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 494-498.
5. Fry MJ. (2001). Breast Cancer Res., 3, 304-312.
6. Gasco M, Shami S and Crook T. (2002). Breast Cancer Res., 4, 70-76.
7. Hayes DF and Thor AD. (2002). Semin. Oncol., 29, 231-245.
8. Hutvagner G and Zamore PD. (2002). Curr. Opin. Genet. Dev., 12, 225-232.
9. Kamalati T, Jolin HE, Fry MJ and Crompton MR. (2000). Oncogene, 19, 5471-5476.
10. Kamalati T, Jolin HE, Mitchell PJ, Barker KT, Jackson LE, Dean CJ, Page MJ, Gusterson BA and Crompton MR. (1996). J. Biol. Chem., 271, 30956-30963.
11. Kim H and Muller WJ. (1999). Exp. Cell Res., 253, 78-87.
12. Lee H, Kim M, Lee KH, Kang KN and Lee ST. (1998). Mol. Cells, 8, 401-407.
13. Llor X, Serfas MS, Bie W, Vasioukhin V, Polonskaia M, Derry J, Abbott CM and Tyner AL. (1999). Clin. Cancer Res., 5, 1767-1777.
14. Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Lowe PN, Page MJ, Gusterson BA and Crompton MR. (1994). Oncogene, 9, 2383-2390.
15. Mitchell PJ, Sara EA and Crompton MR. (2000). Oncogene, 19, 4273-4282.
16. Olayioye MA, Neve RM, Lane HA and Hynes NE. (2000). EMBO J., 19, 3159-3167.
17. Qui H and Miller WT. (2002). J. Biol. Chem., 277, 34634-34641.
18. Tuschl T. (2002). Nat. Biotechnol., 20, 446-448.
19. Vasioukhin V, Serfas MS, Siyanova EY, Polonskaia M, Costigan VJ, Liu B, Thomason A and Tyner AL. (1995). Oncogene, 10, 349-357.
20. Vasioukhin V and Tyner AL. (1997). Proc. Natl. Acad. Sci. USA, 94, 14477-14482.
21. Zeng Y, Wagner EJ and Cullen BR. (2002). Mol Cell, 9, 1327-1333.